Study guide
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications
Medical Council of Canada Qualifying Examination Part I MCCQE Part I
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Blueprint & Canadian Medical Practice
1.1 MCCQE Part I Format, Scoring (439 Scale), & Strategy 1.2 The MCC Blueprint Matrix: Dimensions of Care & Physician Activities 1.3 Canadian Healthcare System, CanMEDS Roles, & Interprofessional Care 1.4 Evidence-Based Medicine, Study Design, & Clinical Statistics
2 Chapter 2: Population Health, Health Promotion & Preventive Care
2.1 Canadian Task Force on Preventive Health Care (CTFPHC) Screening Guidelines 2.2 Immunization Schedules (NACI) & Vaccine-Preventable Diseases across Lifespan 2.3 Disease Prevention, Lifestyle Counselling, & Harm Reduction 2.4 Outbreak Management, Disease Surveillance, & Infection Control 2.5 Occupational, Environmental, & Travel Medicine in Canada
3 Chapter 3: Internal Medicine — Cardiovascular & Respiratory Systems
3.1 Hypertension Canada 2020/2025 Guidelines, Dyslipidemia, & Primary Prevention 3.2 Ischemic Heart Disease, Acute Coronary Syndromes, & Heart Failure Management 3.3 Arrhythmias, Valvular Heart Disease, & Infective Endocarditis 3.4 Asthma, COPD, & Respiratory Failure (CTS Guidelines) 3.5 Thromboembolic Disease (DVT/PE), Pneumonia, & Pleural Effusions
4 Chapter 4: Internal Medicine — GI, Endocrine, Renal & Hematology/Oncology
4.1 Gastrointestinal Disorders, Acute Abdomen, & Liver/Biliary Disease 4.2 Diabetes Canada 2020/2025 Guidelines & Glycemic Management 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances 4.4 Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), & Nephrology 4.5 Hematology, Anemia Evaluation, Transfusion Medicine, & Common Cancers
5 Chapter 5: General Surgery, Orthopedics, & Emergency Care
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications 5.2 Trauma Management (ATLS Protocol) & Burns 5.3 Acute Surgical Conditions (Appendicitis, Cholecystitis, Bowel Obstruction) 5.4 Fractures, Dislocations, Joint Pain, & Musculoskeletal Emergencies 5.5 Vascular Emergencies, Wound Care, & Shock Recognition
6 Chapter 6: Pediatrics & Adolescent Health
6.1 Pediatric Growth, Developmental Milestones, & Well-Child Examinations 6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies 6.3 Pediatric Respiratory Emergencies (Croup, Bronchiolitis, Asthma) 6.4 Common Pediatric Infections, Exanthems, & Fever of Unknown Origin 6.5 Pediatric Abdominal Pain, Dehydration, & Fluid Management
7 Chapter 7: Obstetrics & Gynecology
7.1 Routine Antepartum Care, Screening, & Prenatal Diagnosis (SOGC Guidelines) 7.2 Medical Complications of Pregnancy (Preeclampsia, Gestational Diabetes, Infections) 7.3 Labor, Intrapartum Management, & Postpartum Complications/Hemorrhage 7.4 Abnormal Uterine Bleeding, Gynecologic Infections, & Contraception/Menopause 7.5 Gynecologic Oncology & Pelvic Mass Evaluation
8 Chapter 8: Psychiatry & Mental Health
8.1 Mood Disorders (Depression, Bipolar) & Suicide Risk Assessment 8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders 8.3 Psychotic Disorders & Schizophrenia Management 8.4 Substance Use Disorders, Withdrawal Syndromes, & Harm Reduction 8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
9 Chapter 9: Neurology, Rheumatology, & Dermatology
9.1 Acute Stroke, TIA, & Neurovascular Emergencies 9.2 Headaches, Seizures, Movement Disorders, & Neuromuscular Disease 9.3 Inflammatory Arthritides (RA, Gout, SpA) & Systemic Autoimmune Diseases (SLE, Vasculitis) 9.4 Common Dermatologic Conditions, Cutaneous Manifestations of Systemic Disease, & Skin Cancers 9.5 Musculoskeletal Soft Tissue Injuries, Back Pain, & Physical Medicine
10 Chapter 10: Legal, Ethical, & Professional Behaviours in Canadian Practice
10.1 Informed Consent, Capacity Assessment, & Substitute Decision-Making (CMPA) 10.2 Medical Confidentiality, Privacy Laws (PIPEDA/PHIPA), & Disclosure of Harm 10.3 CMA Code of Ethics, Professionalism, & Physician Health/Boundary Issues 10.4 Mandatory Reporting (Child/Elder Abuse, Driving Safety, Fitness to Practice) & Quality/Safety
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications
Key Takeaways Explain This Topic AI
Functional capacity >= 4 METs (climbing two flights of stairs without symptoms) indicates acceptable perioperative cardiac risk for non-cardiac surgery.
Discontinue SGLT2 inhibitors 3-4 days prior to surgery due to the risk of euglycemic diabetic ketoacidosis (e-DKA).
Postoperative fever follows the '5 Ws' timeline: Wind (atelectasis 24-48h), Water (UTI 48-72h), Wound (SSI 5-7d), Walking (DVT/PE 7-10d), and Wonder drugs/wound deep space (>7d).
Surgical site infections are classified as superficial incisional, deep incisional, or organ/space; superficial infections require suture removal and drainage rather than routine parenteral antibiotics.
Acute postoperative oliguria (<0.5 mL/kg/h for 2 consecutive hours) requires immediate physical evaluation and bladder scan to rule out urinary catheter obstruction before administering IV fluid boluses.
Last updated: July 2026
Preoperative Evaluation, Risk Stratification, & Postoperative Complications
Preoperative evaluation balances surgical urgency against patient-specific physiological risks. The primary objective is not to 'clear' a patient for surgery, but to quantify perioperative risk, optimize chronic medical conditions, and implement risk-reduction strategies. Postoperatively, systematic monitoring enables early recognition of life-threatening surgical complications.
- Preoperative Risk Stratification & Medical Optimization
- Cardiovascular Risk Assessment
Cardiovascular complications are the leading cause of perioperative mortality in non-cardiac surgery. The Canadian Cardiovascular Society (CCS) perioperative guidelines recommend measuring baseline NT-proBNP or BNP in patients aged ≥ 65 \ge 65 ≥ 65 years, or aged 45–64 years with significant cardiovascular disease, to refine risk estimation.
Risk stratification relies on the Revised Cardiac Risk Index (RCRI) , which assigns 1 point for each of the following six independent predictors:
- High-risk surgery (intraperitoneal, intrathoracic, or suprainguinal vascular surgery)
- History of ischemic heart disease (myocardial infarction, positive exercise test, Q waves, angina)
- History of congestive heart failure (pulmonary edema, paroxysmal nocturnal dyspnea, bilateral crackles, S3)
- History of cerebrovascular disease (stroke or transient ischemic attack)
- Preoperative insulin therapy for diabetes mellitus
Preoperative serum creatinine > 170 μ mol/L > 170\ \mu\text{mol/L} > 170 μ mol/L ( > 2.0 mg/dL > 2.0\ \text{mg/dL} > 2.0 mg/dL )
- RCRI Score Risk Class Major Cardiac Event Rate (%) Management Strategy
- 0 Points Class I 0.4% Proceed to elective surgery
- 1 Point Class II 0.9% Proceed with close monitoring; measure post-op troponins
- 2 Points Class III 6.6% Optimize medical therapy; consider cardiology consultation
- ≥ 3 \ge 3 ≥ 3 Points Class IV 11.0% Formal cardiology workup; reconsider surgical risk vs. benefit
Functional capacity is assessed in Metabolic Equivalents of Task (METs) :
< 4 < 4 < 4 METs (Poor): Unable to walk 2 blocks on level ground or climb one flight of stairs. High perioperative risk.
≥ 4 \ge 4 ≥ 4 METs (Good to Excellent): Can climb two flights of stairs carrying groceries, heavy house cleaning, or light sports. Indicates acceptable functional reserve.
💡 MCCQE1 Exam Tip: Patients with poor functional capacity ( < 4 < 4 < 4 METs) and an elevated RCRI score requiring non-urgent surgery should undergo non-invasive stress testing (dobutamine echocardiography or myocardial perfusion imaging). If surgery is emergency or urgent, proceed directly to the operating room with invasive hemodynamic monitoring.
Pulmonary Risk Assessment & ASA Physical Status
Postoperative pulmonary complications (atelectasis, pneumonia, respiratory failure) occur at rates comparable to cardiac events. Risk factors include upper abdominal or thoracic incisions, age > 60 > 60 > 60 years, COPD, smoking, and obstructive sleep apnea (OSA).
Screening for OSA is performed using the STOP-BANG questionnaire (Snoring, Tiredness, Observed apnea, High Blood Pressure, BMI > 35 > 35 > 35 , Age > 50 > 50 > 50 , Neck circumference > 40 cm > 40\text{ cm} > 40 cm , Male Gender). High risk (score ≥ 5 \ge 5 ≥ 5 ) warrants perioperative continuous positive airway pressure (CPAP) planning.
- ASA Physical Status Classification System
- ASA I: Normal healthy patient
ASA II: Mild systemic disease without substantive functional limitations (e.g., controlled HTN, controlled DM, smoker)
ASA III: Severe systemic disease with substantive functional limitations (e.g., poorly controlled DM/HTN, stable angina, history of MI > 3 > 3 > 3 months ago)
ASA IV: Severe systemic disease that is a constant threat to life (e.g., recent MI < 3 < 3 < 3 months ago, ongoing unstable angina, severe valve dysfunction)
- ASA V: Moribund patient not expected to survive without the operation (e.g., ruptured AAA, massive trauma)
- ASA VI: Declared brain-dead patient whose organs are being harvested
- 'E' Modifier: Added for emergency procedures (e.g., ASA III-E)
- Perioperative Medication Management
Appropriate management of chronic medications prevents acute withdrawal, excessive surgical bleeding, and metabolic crises.
Medication Category Preoperative Hold Period Perioperative Management & Rationale
Warfarin Hold 5 days prior Target INR < 1.5 < 1.5 < 1.5 for surgery. Bridge with LMWH/UFH if high VTE or mechanical heart valve risk.
DOACs (Apixaban, Rivaroxaban, Dabigatran) Hold 24–48 hours prior Extend hold to 72 hours for impaired renal function ( C r C l < 50 mL/min CrCl < 50\text{ mL/min} C r Cl < 50 mL/min ) or neuraxial anesthesia.
Aspirin Continue in secondary prevention Continue for ischemic heart disease/stents. Hold 7 days only for high-bleed risk neurosurgery or posterior eye surgery.
Clopidogrel / Ticagrelor Hold 5–7 days prior Hold 5 days for clopidogrel, 7 days for prasugrel. Consult cardiology if drug-eluting stent placed within 12 months.
Metformin Hold day of surgery Prevent lactic acidosis during intraoperative hypoperfusion or contrast administration.
SGLT2 Inhibitors (Empagliflozin, Dapagliflozin) Hold 3–4 days prior Mandatory hold due to severe risk of euglycemic diabetic ketoacidosis (e-DKA) under surgical stress.
Insulin Reduce morning dose Give 50% of NPH/long-acting insulin on morning of surgery. Hold short-acting bolus insulin while NPO.
ACE Inhibitors / ARBs Hold 24 hours prior Discontinue morning of surgery to prevent refractory post-induction vasoplegic hypotension.
Beta-Blockers & Statins CONTINUE Never stop abruptly. Continue on morning of surgery with a sip of water to avoid withdrawal ischemia.
- Postoperative Complications & Diagnostic Timelines
- Postoperative Fever: The "5 Ws"
Postoperative fever is defined as a temperature > 38.0 ∘ C > 38.0^\circ\text{C} > 38. 0 ∘ C ( 100.4 ∘ F 100.4^\circ\text{F} 100. 4 ∘ F ). Causes cluster predictably by postoperative day (POD):
Postoperative Day (POD) Cause ("W") Common Etiology & Pathophysiology Key Diagnostic Workup & Management
POD 1–2 Wind Atelectasis (most common), early hospital-acquired pneumonia Incentive spirometry, chest physiotherapy, early ambulation. Chest X-ray if hypoxemic.
POD 3–5 Water Urinary tract infection (UTI), catheter-associated UTI Urinalysis and urine culture. Remove Foley catheter; targeted IV/oral antibiotics.
POD 5–7 Wound Surgical site infection (SSI - superficial or deep incisional) Inspect incision for erythema, warmth, purulence. Open wound, drain fluid, send Gram stain/culture.
POD 7–10 Walking Deep vein thrombosis (DVT), Pulmonary embolism (PE) Bilateral leg duplex US; CT pulmonary angiography (CTPA). Anticoagulation if confirmed.
POD > 7 > 7 > 7 / Any time Wonder Drugs / What we did Drug fever, intra-abdominal abscess, anastomotic leak, line infection Abdominal CT scan with IV/oral contrast for deep abscess. Blood cultures, line tip cultures.
⚠️ Clinical Scenario: A 62-year-old male on POD 6 following anterior resection develops a temperature of 38.8 ∘ C 38.8^\circ\text{C} 38. 8 ∘ C , tachycardia (115 bpm), and localized lower abdominal tenderness with cloudy purulent fluid leaking between skin staples. Next Step: Remove skin staples bedside, open the incision, obtain wound cultures, and dress with wet-to-dry packing. Parenteral antibiotics are reserved for surrounding cellulitis, systemic sepsis, or deep fascial involvement.
Surgical Site Infections (SSI)
SSIs are categorized into three anatomical tiers:
Superficial Incisional: Involves skin and subcutaneous tissue only. Managed by suture/staple removal, drainage, and local wound care.
Deep Incisional: Involves fascia and muscle layers. Requires operative debridement, tissue cultures, and systemic antibiotics.
Organ/Space: Involves intra-abdominal, intrathoracic, or joint cavities (e.g., intra-abdominal abscess post-colectomy). Requires percutaneous image-guided catheter drainage or surgical re-exploration plus IV broad-spectrum antibiotics.
Postoperative Oliguria & Acute Kidney Injury
Oliguria is defined as urine output < 0.5 mL/kg/h < 0.5\ \text{mL/kg/h} < 0.5 mL/kg/h for 2 consecutive hours. The approach requires rapid differentiation between obstructive (postrenal), hypovolemic (prerenal), and intrinsic renal etiologies.
Step 1 (Rule out obstruction): Inspect catheter for kinks. Perform a bedside bladder scan or flush the Foley catheter with 30 mL 30\text{ mL} 30 mL sterile saline.
Step 2 (Evaluate volume status): Assess blood pressure, heart rate, CVP, skin turgor, and fluid balance records.
Step 3 (Fluid challenge): Administer a 500 mL 500\text{ mL} 500 mL isotonic crystalloid bolus over 30 minutes if prerenal azotemia is suspected.
Step 4 (Investigate intrinsic failure): If urine output does not respond to fluid resuscitation, order serum electrolytes, creatinine, urinalysis, fractional excretion of sodium ( F E N a FE_{Na} F E N a ), and renal ultrasound.
Wound Dehiscence vs. Evisceration
Wound Dehiscence: Separation of fascial layers without protrusion of intra-abdominal contents. Classic sign: profuse salmon-pink, serosanguinous wound discharge on POD 4–8. Managed with abdominal binder, bed rest, and surgical repair of fascia.
Evisceration: Surgical emergency defined as fascial separation with protrusion of abdominal viscera (bowel loops) through the skin incision.
Immediate Management: Cover exposed bowel with warm, sterile saline-soaked gauze , place patient in low Fowler position with knees flexed, keep strictly NPO, administer IV broad-spectrum antibiotics, and notify the surgical team for emergent return to the operating room .